Fig. 1
Effect of empagliflozin on estimated fluid volume status through week 24. eEV estimated extracellular volume, eGD estimated group difference, ePV estimated plasma volume
Fig. 1 | Cardiovascular Diabetology
Effect of empagliflozin on estimated fluid volume status through week 24. eEV estimated extracellular volume, eGD estimated group difference, ePV estimated plasma volume
Cardiovascular Diabetology